Results 251 to 260 of about 257,683 (336)
The regimen of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R‐CHOP) is the first‐line treatment for non‐Hodgkin lymphoma (NHL). Nine articles involving 331 patients were included in the meta‐analysis, the pooled proportion of reproductive adverse events was 22.3% (95% CI 11.4%–33.2%; p < 0.001). The findings
Rong Han+6 more
wiley +1 more source
ABSTRACT Efficacy and safety of ibrutinib 560 mg once daily or placebo combined with bendamustine and rituximab (BR) were assessed in patients with mantle cell lymphoma in a randomized phase 3 study (SHINE). The analysis described explores the ibrutinib population pharmacokinetics (PK) and exposure‐response (E‐R) relationships of selected efficacy and ...
Per Olsson Gisleskog+5 more
wiley +1 more source
Prompt Autologous Hematopoietic Stem Cell Transplant in Patients With Large B-Cell Lymphoma Is Associated With Lower Rates of Progression of Disease Prior to Transplant. [PDF]
Dean EA+7 more
europepmc +1 more source
Malignancies and immunoglobulin G4‐related disease
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley +1 more source
The short-term Cardiotoxicity after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective single center experience. [PDF]
El Cheikh J+9 more
europepmc +1 more source
Neut‐GI and Re‐Lymp levels correlated with changes in SLEDAl‐2K scores. Specifically, increasing in SLEDAl‐2K scores was associated with decreasing in extended inflammatory parameters. Thus, Neut‐Gland Re‐Lymp might serve as simpler and more cost‐effective alternatives to SLEDAI‐2K scores for monitoring changes in SLE activity.
Galuh Setyorini+5 more
wiley +1 more source
The final systemic sclerosis patients with interstitial lung disease (SSc‐ILD) progression prediction model was composed of 6 significant risk factors: male, type 2 diabetes mellitus, pericardial effusion, anti‐Ro52, hypoproteinemia, and elevated C‐reactive protein. Our model demonstrated excellent prognostic utility.
Xi Cao+6 more
wiley +1 more source
How to Choose Treatment Regimens for Idiopathic Membranous Nephropathy Patients with PLA2R-Negative: A Single-Center Retrospective Cohort Study. [PDF]
Zhou Z, Zou Y, Ke B, Shen W.
europepmc +1 more source
Methanolic extract of <i>Justicia secunda</i> ameliorates the cyclophosphamide-induced hepatic and renal failures in rats. [PDF]
Kalu WO+4 more
europepmc +1 more source